微电生理1月26日获融资买入4009.15万元，融资余额3.65亿元

Core Viewpoint - Microelectrophysiology experienced a decline of 5.10% on January 26, with a trading volume of 243 million yuan, indicating market volatility and investor sentiment towards the company [1] Group 1: Financial Performance - For the period from January to September 2025, Microelectrophysiology achieved a revenue of 336 million yuan, representing a year-on-year growth of 15.65% [2] - The net profit attributable to shareholders for the same period was 41.92 million yuan, showing a slight increase of 0.46% year-on-year [2] Group 2: Shareholder and Market Activity - As of September 30, 2025, the number of shareholders for Microelectrophysiology reached 9,580, an increase of 9.00% compared to the previous period [2] - The average number of circulating shares per shareholder decreased by 8.26% to 13,033 shares [2] - On January 26, the financing buy-in amount was 40.09 million yuan, with a net buy of 15.28 million yuan, indicating strong investor interest [1] - The total financing and securities balance for Microelectrophysiology was 366 million yuan, accounting for 11.91% of the circulating market value, which is above the 90th percentile of the past year [1] Group 3: Institutional Holdings - As of September 30, 2025, the largest circulating shareholder was Huatai-PineBridge Innovation Medical Mixed A, holding 4.73 million shares, an increase of 308,600 shares from the previous period [3] - The second-largest shareholder, Huatai-PineBridge Medical Service Flexible Allocation Mixed A, reduced its holdings by 2.98 million shares to 4.26 million shares [3] - New institutional investors included Hong Kong Central Clearing Limited, which entered the top ten shareholders with 1.87 million shares [3]